Product Portfolio
LxBio forecast market release calendar:
Diabetic Foot Infection
Respiratory Infection
Ophthalmology (non-disclosed)
Neuropatic pain (non-disclosed)
- 34.19%
- 22.03%
- 9.91%
- 8.54%
3Q 2025
3Q 2027
2034
2036
- Diabetic Foot Infection [ 3Q 2025 ] 34.19%
- Respiratory Infection [ 3Q 2027 ] 22.03%
- Ophthalmology (non-disclosed) [ 2034 ] 9.91%
- Neuropatic pain (non-disclosed) [ 2036 ] 8.54%